Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.77
+0.73 (2.70%)
At close: Jul 31, 2026, 4:00 PM EDT
27.60
-0.17 (-0.61%)
After-hours: Jul 31, 2026, 7:58 PM EDT
Hims & Hers Health Market Cap
Hims & Hers Health has a market cap or net worth of $6.43 billion as of July 31, 2026. Its market cap has decreased by -56.18% in one year.
Market Cap
6.43B
Enterprise Value
6.81B
1-Year Change
-56.18%
Ranking
Category
Stock Price
$27.77
ChartMarket Cap Chart
Since September 13, 2019, Hims & Hers Health's market cap has increased from $246.53M to $6.43B, an increase of 2,507.21%. That is a compound annual growth rate of 60.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.43B | -13.04% |
| Dec 31, 2025 | 7.39B | 39.92% |
| Dec 31, 2024 | 5.28B | 180.00% |
| Dec 29, 2023 | 1.89B | 41.69% |
| Dec 30, 2022 | 1.33B | -0.30% |
| Dec 31, 2021 | 1.34B | 263.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 13.22B |
| Dr. Reddy's Laboratories | 9.98B |
| Alkermes | 8.41B |
| Liquidia | 7.72B |
| Lantheus Holdings | 6.60B |
| Kiniksa Pharmaceuticals International, | 6.08B |
| Amneal Pharmaceuticals | 5.83B |
| Indivior Pharmaceuticals | 4.88B |